Fuji Pharma Co

Fuji Pharma Co Current Liabilities

The Current Liabilities of Fuji Pharma Co (4554.T) as of Oct 18, 2026 is 34.66 B JPY. In the previous year, Current Liabilities was 42.46 B JPY — a change of -18.38% (lower).

Current Liabilities

34.66 BJPY

YoY

-18.38%

Last updated:

Current Liabilities of Fuji Pharma Co is 2025 34.66 B JPY. Current Liabilities of Fuji Pharma Co was 2024 42.46 B JPY. It decreases by -18.38% lower compared to the previous year.

The Fuji Pharma Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
12.89 B JPY
Jan 1, 2019
14.87 B JPY
Jan 1, 2020
12.68 B JPY
Jan 1, 2021
21.87 B JPY
Jan 1, 2022
27.78 B JPY
Jan 1, 2023
34.43 B JPY
Jan 1, 2024
42.46 B JPY
Jan 1, 2025
34.66 B JPY
The Fuji Pharma Co Current Liabilities history
YEARCurrent LiabilitiesYoY
34.66 BJPY-18.38%
42.46 BJPY+23.32%
34.43 BJPY+23.93%
27.78 BJPY+27.03%
21.87 BJPY+72.50%
12.68 BJPY-14.72%
14.87 BJPY+15.39%
12.89 BJPY+11.81%
11.52 BJPY-20.18%
14.44 BJPY+27.48%
11.33 BJPY-9.86%
12.56 BJPY+27.20%
9.88 BJPY+21.40%
8.14 BJPY+13.25%
7.18 BJPY+43.88%
4.99 BJPY+0.73%
4.96 BJPY-9.83%
5.50 BJPY+1.87%
5.40 BJPY+35.71%
3.98 BJPY+22.15%
3.26 BJPY-10.82%
3.65 BJPY+41.86%
2.57 BJPY+22.41%
2.10 BJPY+8.69%
1.93 BJPY+21.48%
1.59 BJPY-23.94%
2.09 BJPY+56.66%
1.34 BJPY-0.96%
1.35 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fuji Pharma Co Stock analysis

What does Fuji Pharma Co do? Fuji Pharma Co Ltd is a Japanese company specializing in the healthcare industry. The company was founded in 2001 and is headquartered in Tokyo, Japan. It is listed on the Tokyo Stock Exchange and employs over 1,000 employees. Fuji Pharma's business model is to provide its customers with innovative and high-quality products that contribute to improving health and well-being. The company specializes in several business areas, including the development, manufacturing, and marketing of pharmaceutical products, production of OEM products for other companies, and manufacturing of dietary supplements and cosmetics. An important area for Fuji Pharma is the development and production of pharmaceuticals. The company ensures that its medications meet the highest requirements and international standards. This includes research and development of new products. The company has its own research department specializing in the development of medications that can be used in serious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, Fuji Pharma is also involved in the production of OEM products for other companies. The company ensures the manufacture of medications and medical products for other pharmaceutical companies, meeting the highest quality standards and customer requirements. Fuji Pharma is proud to be a trusted partner for its customers and provides its services according to the requirements of its customers. In addition to these two divisions, Fuji Pharma also produces dietary supplements and cosmetics for the domestic and international markets. These products are designed for consumers who want to improve their health and well-being. The company places great emphasis on the development of natural and safe ingredients for its products and ensures the highest standards of quality and safety. Fuji Pharma has also specialized in the Japanese market for medical devices, particularly in the field of home respiratory devices. The company has developed a new generation of respiratory therapy devices that are safe and easy to use, providing better well-being and quality of life for patients with respiratory diseases. In addition to its business areas, Fuji Pharma also has various products in its portfolio that are known for their quality and effectiveness. One such product is "Efil," a medication used in the treatment of erectile dysfunction disorders. The medication is available in Japan and other Asian countries and has already been used by over 200,000 patients. Fuji Pharma continuously strives to improve its research and development activities and develop new innovative products and services for the healthcare industry. The company aims to bring its products and services to the international market and satisfy its customers in Japan and worldwide. Fuji Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fuji Pharma Co stock

Current Liabilities of Fuji Pharma Co is 34.66 B JPY in 2025.

Current Liabilities of Fuji Pharma Co changed from 42.46 B JPY to 34.66 B JPY, representing a -18.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Fuji Pharma Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Fuji Pharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Fuji Pharma Co

All Key Metrics — Fuji Pharma Co